CSIMarket
 
Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 



EARNINGS REPORT by CSIMarket

Sharp drop in EPS, Sales Faded

Biogen Inc announced fourth quarter 2020 operating deficit of $-330.7 millions, company lowers it's earnings outlook.

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonsSales contraction of -22.3 % caused drop in earnings by -71.27 % for the fourth quarter 2020. Company posted results of $2.85 billions in Sales this compares to $3.67 billions a year ago and eps of $2.32 per share compare to 8.09 in previous year.

In contrast to the third quarter 2020 Sales fell by -15.51 % from $3.38 billions and profit plummeted by -47.89 % from $4.46 per share.
Sales fell at AVONEX -20.5%, TYSABRI -13.18%, FAMPYRA -5.38%, while revenue growth was achieved at TECFIDERA +26.11%, ALPROLIX +423.08%.
Net income of $357.500 millions in the fourth quarter 2020 fell by -75.17 % from $1,439.700 millions in the corresponding period a year before. Company has decreased it's eps guidance, by $-1.18 to the new range between $14.25 and $ 14.70, while company see it's Sales estimates at $11,159 millions.
Looking into financial results for the fiscal year 2020, Biogen Inc reported Sales of $13.44 billions and net income of $4.06 billions.

Biotechnology & Drugs Company explained also, that Earnings deteriorated by -21.07 % to $24.80 per share from $31.42 in the previous fiscal year, while Sales decreased by -6.49 % from $14.38 billions a year ago.

Biogen Inc is expected to report next financial results on April 22, 2021.


    Recently Reported Results
pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Rigel Pharmaceuticals Inc

Biogen Inc announced fourth quarter 2020 operating deficit of $-330.7 millions, company lowers it's earnings outlook.

Sales contraction of -22.3 % caused drop in earnings by -71.27 % for the fourth quarter 2020. Company posted results of $2.85 billions in Sales this compares to $3.67 billions a year ago and eps of $2.32 per share compare to 8.09 in previous year.

Income faded from the preceding quarter from $-0.08 per share, Sales increased by 0.33 % from $18.39 millions.
Rigel Pharmaceuticals Inc reported net loss of $-29.74 millions and Sales of $108.62 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.18 from $-0.40 in the previous fiscal year, while Sales surged by 83.21 % from $59.29 millions a year ago.

RIGL stock quotes, charts, profile

Growth Rates, Profitability, PE

TPIRWordmark Producer Price Index

Wholesale prices up but core declined


ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_Common Luxfer Holdings Plc

Luxfer Holdings Plc announced fourth quarter of 2020 earnings season operating income of $9.7 millions

In the fourth quarter of 2020 earnings season Luxfer Holdings Plc earnings turn positive of $0.25 per share compared to $-0.08 a year ago and eps more than doubled by 181.66 % from $0.09 per share from the previous quarter.

Sales fell sharply by -58.69% to $41.10 millions from $99.50 millions in the same quarter a year ago and sequentially Sales Tumbled by -54.54% from $90.40 millions.
In the fiscal year 2020, Luxfer Holdings Plc reported Sales of $324.80 millions and net income of $20.00 millions.

Eps surged by 554.55 % to $0.72 per share from $0.11 in the previous fiscal year, while Sales fell by -26.76 % from $443.50 millions a year ago.

LXFR stock quotes, charts, profile

Growth Rates, Profitability, PE

beachlanding_By_Dale_Coleman__[GFDL 1.2_(www.gnu.org_licenses_old-licenses_fdl-1.2.html)] Jetblue Airways Corp

Jetblue Airways Corp announced financial time frame ending Dec 31 2020 operating loss of $-454 millions

Jetblue Airways Corp reported disastrous financial time frame ending Dec 31 2020, where Sales faded by -67.42% to $662.00 millions and loss per share has widen to $-1.29, from the same quarter a year ago.

Eps more than doubled from the preceding quarter from $-1.44 per share, Sales surged by 34.55 % from $492.00 millions.
Jetblue Airways Corp reported net loss of $-1,354.00 millions and Sales of $2.96 billions for the fiscal year 2020.

Company recorded loss per share of $-4.88 compared to $1.91 in the previous fiscal year, while Sales Tumbled by -63.47 % from $8.09 billions a year ago.

JBLU stock quotes, charts, profile

Growth Rates, Profitability, PE

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Neuronetics Inc

Neuronetics Inc announced fourth quarter of 2020 operating loss of $-2.66 millions

In the fourth quarter of 2020 Neuronetics Inc lost money of $-0.19 per share compared to $-0.41 a year ago and increased losses from $-0.18 per share from the previous quarter.

Sales declined in double digits by -10.24% to $15.58 millions from $17.36 millions in the same quarter a year ago and sequentially Sales improved by 25.15 % from $12.45 millions.
Neuronetics Inc reported net loss of $-27.45 millions and Sales of $49.24 millions for the fiscal year 2020.

Company has decreased loss per share to $-1.46 from $-1.58 in the previous fiscal year, while Sales fell by -21.41 % from $62.66 millions a year ago.

STIM stock quotes, charts, profile

Growth Rates, Profitability, PE

house-1525913_960_720 Housing Starts

Construction of new homes in U.S. continued to grow in December


Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Durable Goods Orders

New orders accelerate in December

New orders increased on the faster pace again, excluding defense booking grew even faster 1.05 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.

Factory Orders (Picture Autor: Wolfgang Meinhart) licence GNU Factory Orders

New Orders up 1.29 % in December

Factory orders continued to grow, excluding defense, booking grew even faster 1.56 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.

Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons Glycomimetics Inc

Turn into Profitability, Revenues Unchanged

In the fiscal time frame ending Dec 31 2020 Glycomimetics Inc turn a round of $0.45 per share compared to $-0.34 a year ago and EPS turn positive from $-0.29 per share from the previous quarter.

Sales remained unchanged to $0.16 millions from $0.00 millions in the same quarter a year ago and sequentially Sales improved by -83.71% from $1.00 millions.
Glycomimetics Inc reported net loss of $0.00 millions and Sales of $10.16 millions for the fiscal year 2020.

Company has decreased loss per share to $-1.12 from $-1.34 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

GLYC stock quotes, charts, profile

Growth Rates, Profitability, PE

Prosciutto_con_melone_By_Nikodem_Nijaki_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons B and g Foods inc

B And G Foods Inc announced most recent fiscal period operating profit of $43.307 millions

Sales for the most recent fiscal period increased by 8.52% to $510.24 millions in comparison to $470.17 millions on a year-over-year basis, company posted earnings growth of 17.02 % to $0.19, as comparison at $0.16 in the prior year quarter.

In contrast to the third quarter Sales increased by 2.92 % from $495.76 millions and eps dropped by -73.96% from $0.72 per share.
In the fiscal year 2020, B And G Foods Inc reported Sales of $1.97 billions and net income of $131.99 millions.

Eps soared by 74.36 % to $2.04 per share from $1.17 in the previous fiscal year, while Sales improved by 18.52 % from $1.66 billions a year ago.

BGS stock quotes, charts, profile

Growth Rates, Profitability, PE

By_Elke_Wetzig(Elya_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons Cellectar Biosciences Inc

Cellectar Biosciences Inc announced financial fourth quarter of 2020 operating shortfall of $-3.799523 millions

In the financial fourth quarter of 2020 Cellectar Biosciences Inc decreased loss of $-0.12 per share compared to $-0.35 a year ago and improved from $-0.15 per share from the previous quarter.

Cellectar Biosciences Inc reported operating shortfall of $-3.799523 millions, in the financial fourth quarter of 2020, a deterioration from the operating shortfall of $-3.384574 millions, realized in fourth quarter of 2019
Cellectar Biosciences Inc reported net loss of $-15.09 millions and Sales of $0.00 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.76 from $-1.84 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

CLRB stock quotes, charts, profile

Growth Rates, Profitability, PE

server-90389_960_720 Workday Inc

Workday Inc announced financial period ending Jan 31 2021 operating shortfall of $-326.942 millions

Workday Inc reported disastrous financial period ending Jan 31 2021, where Sales faded by -54.84% to $440.89 millions and loss per share has widen to $-1.34, from the same quarter a year ago.

Eps dropped from the preceding quarter from $-0.10 per share, Sales Tumbled by -60.13% from $1.11 billions.
Workday Inc reported net loss of $-282.43 millions and Sales of $4.32 billions for the fiscal year 2021.

Company has decreased loss per share to $-1.19 from $-2.12 in the previous fiscal year, while Sales improved by 19.04 % from $3.63 billions a year ago.

WDAY stock quotes, charts, profile

Growth Rates, Profitability, PE

welding_pd Pgt Innovations Inc

Pgt Innovations Inc announced fiscal time frame ending Jan 02 2021 operating surplus of $19.26 millions

Pgt Innovations Inc showed respectable growth in the fiscal time frame ending Jan 02 2021, where earnings per share more than doubled by 200.46 % year on year to $0.17 per share and Sales increased by 26.76% to $221.60 millions.

Sequentially profit plummeted by -42.35% from $0.29 per share and Sales decreased by -6.9% from $238.03 millions.
In the fiscal year 2020, Pgt Innovations Inc reported Sales of $882.62 millions and net income of $45.11 millions.

Income improved by 2.7 % to $0.76 per share from $0.74 in the previous fiscal year, while Sales improved by 18.48 % from $744.96 millions a year ago.

PGTI stock quotes, charts, profile

Growth Rates, Profitability, PE

rent_a_car_single_Avis_pd Aercap Holdings n v

Fourth quarter Profits vanish on impairment charges

Aercap Holdings N V revalues its goodwill and intangible assets, by taking $1,086.98 million charge in the fourth quarter of 2020 earnings season

In the previous quarter company realized Sales of $0.00 millions and bottom line of $0.00 per share.
Aercap Holdings N V reported net loss of $-294.92 millions and Sales of $4.49 billions for the fiscal year 2020.

Company recorded loss per share of $-2.34 compared to $8.43 in the previous fiscal year, while Sales deteriorated by -8.99 % from $4.94 billions a year ago.

AER stock quotes, charts, profile

Growth Rates, Profitability, PE



Other BIIB's Earnings Reports

Biogen Inc reported third quarter 2020 earnings

Biogen Inc reported second quarter 2020 earnings

Biogen Inc reported first quarter 2020 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GTS's Profile

Stock Price

GTS's Financials

Business Description

Fundamentals

Charts & Quotes

GTS's News

Suppliers

GTS's Competitors

Customers & Markets

Economic Indicators

GTS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071